Ignite Creation Date:
2025-12-24 @ 3:31 PM
Ignite Modification Date:
2026-01-02 @ 8:37 AM
Study NCT ID:
NCT00075192
Status:
COMPLETED
Last Update Posted:
2012-06-06
First Post:
2004-01-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CP-675,206 With Neoadjuvant Hormone Therapy in Patients With High Risk Prostate Cancer
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-03
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2006-03
Completion Date Type:
ACTUAL
First Submit Date:
2004-01-05
First Submit QC Date:
None
Study First Post Date:
2004-01-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-06-05
Last Update Post Date:
2012-06-06
Last Update Post Date Type:
ESTIMATED